Suresh Maharjan, MD
Internal Medicine · Santa Clara
- Medicare standing
- Clear
- Enrolled, allowed to bill and order, not excluded
- Plans that list them
- 4
- 1 carrier
- Office
- 1
Offices
1 location · Permanente Medical Group Inc · 10,928 clinicians in this group
Plans that list them
4 plans · 1 carrier
A missing listing does not mean out of network. Directories change, and a listing does not cover every office. Call Dr. Maharjan’s office at (408) 851-1000 to confirm they take your plan. Ask about the office you use, its medical group, referrals and appointments.
| Kaiser Permanente Dual Complete North P2 (HMO D-SNP) | Kaiser Permanente | Listed | Sep 1, 2026 |
| Kaiser Permanente Dual Complete North P23 (HMO D-SNP) | Kaiser Permanente | Listed | Sep 1, 2026 |
| Kaiser Permanente Sr Adv Basic Santa Clara (HMO) | Kaiser Permanente | Listed | Sep 1, 2026 |
| Kaiser Permanente Sr Adv Enhanced Santa Clara (HMO) | Kaiser Permanente | Listed | Sep 1, 2026 |
California Medical Board record
Licence A161928 · Current
Licensed to practise in California · since 2019 · expires 2027-04-30 · University of Science Technology Chittagong, Institute of Applied Health Sciences.
No disciplinary actions, convictions, malpractice judgments or citations in this record.
Medicaid work
$3,370 in 2019
Medicaid paid $3,370 for 26 billed services this clinician did in 2019, up to 13 people in a month for one service.
Medicaid and CHIP claims where this clinician did the service, fee-for-service and managed care together. Any month with fewer than 11 patients is hidden, so small Medicaid practices undercount.
| Clinic visit/encounter, all-inclusive | 26 | $3,370 |
| 2019 | 26 | 1 | 13 | $3,370 |
| 2018 | 41 | 1 | 17 | $4,952 |
See the largest Medicaid services in earlier years
2018
| Clinic visit/encounter, all-inclusive | 41 | $4,952 |
Drugs they prescribed that Part D paid
$1,011,583
Pharmacies billed $1,011,583 in 2024.
This is pharmacy cost, not the office bill, and not what patients paid.
Opioids were 0% of their Part D prescriptions (0 of 1,418) in 2024. At or below the middle of the specialty; the typical internal medicine clinician is at 1%.
1,026 generic and fewer than 11 brand-name prescriptions · $1,011,583 in drug cost.
Part D prescriptions only. The opioid rate is opioid prescriptions as a share of all this clinician's Part D prescriptions; surgeons and pain specialists run higher than others, so it is shown against the same specialty.
| Enbrel Sureclick | 44 | $246,802 | $5,609 |
| Enbrel | 33 | $171,155 | $5,187 |
| Rasuvo | 102 | $73,816 | $724 |
| Amjevita(Cf) | 47 | $53,323 | $1,135 |
| Xeljanz | 15 | $44,628 | $2,975 |
See all 15 drugs
| Enbrel Sureclick | 44 | $246,802 | $5,609 |
| Enbrel | 33 | $171,155 | $5,187 |
| Rasuvo | 102 | $73,816 | $724 |
| Amjevita(Cf) | 47 | $53,323 | $1,135 |
| Xeljanz | 15 | $44,628 | $2,975 |
| Amjevita(Cf) | 22 | $35,914 | $1,632 |
| Methotrexate | 325 | $6,300 | $19 |
| Hydroxychloroquine Sulfate | 149 | $4,962 | $33 |
| Mycophenolate Mofetil | 21 | $4,180 | $199 |
| Leflunomide | 117 | $3,453 | $30 |
| Prednisone | 228 | $2,389 | $10 |
| Sulfasalazine | 43 | $2,308 | $54 |
| Azathioprine | 27 | $897 | $33 |
| Leucovorin | 25 | $363 | $15 |
| Allopurinol | 39 | $343 | $9 |
Year by year
| 2024 | 1,418 | 325 | 0% (0) | None | $1,011,583 |
| 2023 | 1,098 | 353 | 0% (0) | None | $742,930 |
| 2022 | 290 | 80 | 0% (0) | None | $465,309 |
| 2021 | 176 | 46 | 0% (0) | None | $280,912 |
| 2020 | 216 | 104 | None | 25% | $25,970 |
Part D prescriptions only. A drug prescribed to fewer than 11 people in a year is hidden.
See the drugs prescribed each year
2023: 19 drugs
| Enbrel Sureclick | 30 | $153,015 | $5,100 |
| Enbrel | 19 | $92,806 | $4,885 |
| Humira(Cf) | 12 | $73,058 | $6,088 |
| Amjevita(Cf) | 32 | $63,008 | $1,969 |
| Xeljanz | 23 | $59,258 | $2,576 |
| Orencia | 12 | $54,100 | $4,508 |
| Rasuvo | 72 | $45,840 | $637 |
| Amjevita(Cf) | 12 | $31,417 | $2,618 |
| Mycophenolate Mofetil | 23 | $9,331 | $406 |
| Methotrexate | 247 | $4,549 | $18 |
| Hydroxychloroquine Sulfate | 106 | $3,697 | $35 |
| Leflunomide | 88 | $2,723 | $31 |
| Prednisone | 181 | $2,321 | $13 |
| Diclofenac | 31 | $1,256 | $41 |
| Sulfasalazine | 17 | $852 | $50 |
| Azathioprine | 24 | $789 | $33 |
| Colchicine | 14 | $245 | $17 |
| Allopurinol | 25 | $239 | $10 |
| Alendronate | 12 | $115 | $10 |
2022: 5 drugs
| Enbrel Sureclick | 16 | $101,527 | $6,345 |
| Hydroxychloroquine Sulfate | 45 | $2,951 | $66 |
| Methotrexate | 55 | $2,094 | $38 |
| Prednisone | 36 | $438 | $12 |
| Sulfasalazine Dr | 11 | $418 | $38 |
2021: 4 drugs
| Humira(Cf) | 14 | $196,238 | $14,017 |
| Hydroxychloroquine Sulfate | 18 | $1,177 | $65 |
| Methotrexate | 29 | $1,040 | $36 |
| Prednisone | 34 | $362 | $11 |
2020: 6 drugs
| Diclofenac | 38 | $2,300 | $61 |
| Alvesco | 14 | $1,351 | $97 |
| Methotrexate | 13 | $683 | $53 |
| Ventolin Hfa | 14 | $674 | $48 |
| Prednisone | 15 | $136 | $9 |
| Amlodipine Besylate | 11 | $95 | $9 |
Money from drug and device companies
$99 in 2022
| 2022 | 1 | 1 | None | $99 |
| 2021 | 1 | 2 | None | $198 |
| 2020 | 1 | 1 | None | $91 |
| 2019 | 1 | 1 | None | $90 |
Paid work is consulting, speaking, honoraria and royalties, as opposed to meals and travel.
A payment is not proof that care is biased.
| Janssen Biotech | Tremfya | $99 | 1 payment
|
See the published payment
| Janssen Biotech | Education · 2022-02-15 | Tremfya | $99 |
See earlier years (2021, 2020, 2019)
2021: $198
| Janssen Biotech | Tremfya | $198 | 2 payments
|
2020: $91
| Genentech USA | None | $91 | 1 payment
|
2019: $90
| GlaxoSmithKline | Benlysta | $90 | 1 payment
|
Professional record
- NPI
- 1194189704
- Licence
- CA A161928California A161928: Current · expires 2027-04-30
- Video visits
- Lists video visits
- Gender
- Male
More record details
- Sole proprietor
- No
- Taxonomy
- Federal specialty code 207RR0500X (207RR0500X); Internal medicine (207R00000X); Student in a training program (390200000X)
- Mailing address
- 700 Lawrence Expy, Santa Clara, CA, 95051
- NPI first listed
- 2016-04-09
- NPI last updated
- 2024-02-01
- NPI record certified
- 2024-02-01
This is when the NPI record was last certified, not a medical board exam.
This office lists an electronic records connection.